Radice Law Firm is one of class counsel for plaintiffs in an antitrust class action alleging that several drug manufacturers conspired to raise the price of generic digoxin and doxycycline far above competitive levels.  The case was recently consolidated in federal district court in the Eastern District of Pennsylvania where consolidated class action complaints will be filed in early 2017.